These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2106004)

  • 1. Free and antibody-complexed antigen and antibody profile in apparently healthy HIV seropositive individuals and in AIDS patients.
    Portera M; Vitale F; La Licata R; Alesi DR; Lupo G; Bonura F; Romano N; Di Cuonzo G
    J Med Virol; 1990 Jan; 30(1):30-5. PubMed ID: 2106004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 neutralizing antibodies in urine from seropositive individuals.
    Cao YZ; Friedman-Kien AE; Mirabile M; Li XL; Alam M; Dieterich D; Ho DD
    J Acquir Immune Defic Syndr (1988); 1990; 3(3):195-9. PubMed ID: 1968094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An ELISA-inhibition assay for antibody to human immunodeficiency virus core antigen (p24).
    Povolotsky J; Gold JW; Darminin P; Chein N; Baron P; Armstrong D
    J Virol Methods; 1990 Oct; 30(1):109-14. PubMed ID: 2128300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood antigens and specific anti-core and anti-envelope antibodies as markers of the course of HIV infection].
    Sorice F; Vullo V; Cirelli A; Catania S; Mastroianni CM; Contini C; Delia S
    Boll Ist Sieroter Milan; 1989; 68(2):115-21. PubMed ID: 2562362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential maturation of avidity of IgG antibodies to gp41, p24 and p17 following infection with HIV-1.
    Thomas HI; Wilson S; O'Toole CM; Lister CM; Saeed AM; Watkins RP; Morgan-Capner P
    Clin Exp Immunol; 1996 Feb; 103(2):185-91. PubMed ID: 8565298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic value of antibodies against HIV-1 proteins in seropositive drug addicts tested by the western blotting method].
    Swiderska H; Kalinowska B
    Przegl Epidemiol; 1992; 46(1-2):19-25. PubMed ID: 1475386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and persistence of antibody titers to recombinant HIV-1 core and matrix proteins in HIV-1 infection.
    Janvier B; Mallet F; Cheynet V; Dalbon P; Vernet G; Besnier JM; Choutet P; Goudeau A; Mandrand B; Barin F
    J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):898-903. PubMed ID: 8315575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of specific antibodies to human immunodeficiency virus structural proteins: clinical significance.
    Allain JP; Laurian Y; Einstein MH; Braun BP; Delaney SR; Stephens JE; Daluga CK; Dahlen SJ; Knigge KM
    Blood; 1991 Mar; 77(5):1118-23. PubMed ID: 1671648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminating between protective and enhancing HIV antibodies.
    Bernard J; Reveil B; Najman I; Liautaud-Roger F; Fouchard M; Picard O; Cattan A; Mabondzo A; Laverne S; Gallo RC
    AIDS Res Hum Retroviruses; 1990 Feb; 6(2):243-9. PubMed ID: 2109624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive markers for the acquired immunodeficiency syndrome (AIDS) in hemophiliacs: persistence of p24 antigen and low T4 cell count.
    Eyster ME; Ballard JO; Gail MH; Drummond JE; Goedert JJ
    Ann Intern Med; 1989 Jun; 110(12):963-9. PubMed ID: 2567142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of HIV: correlation with clinical, virological, and immunological status.
    O'Shea S; Rostron T; Hamblin AS; Palmer SJ; Banatvala JE
    J Med Virol; 1991 Sep; 35(1):65-9. PubMed ID: 1940886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral gene expression, antibody production and immune complex formation in human immunodeficiency virus infection.
    Lange JM; Paul DA; de Wolf F; Coutinho RA; Goudsmit J
    AIDS; 1987 May; 1(1):15-20. PubMed ID: 3122785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of antibody response to recombinant HIV-1 gene-encoded products nef, rev, tat, and protease in predicting development of AIDS in HIV-1-infected individuals.
    Reiss P; de Wolf F; Kuiken CL; de Ronde A; Dekker J; Boucher CA; Debouck C; Lange JM; Goudsmit J
    J Acquir Immune Defic Syndr (1988); 1991; 4(2):165-72. PubMed ID: 1898969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of antibodies to p24 and gp41 epitopes of HIV by ELISA using the recombinant core protein (p24) and envelope synthetic protein (gp41).
    Filice G; Soldini L; Orsolini P; Razzini E; Chiapparoli L; Gulminetti R; Cattaneo E; Achilli G
    Microbiologica; 1991 Jan; 14(1):1-7. PubMed ID: 1906127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
    Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
    Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between cell-free viraemia, antigenaemia and antibody levels in HIV-1-infected Ethiopian patients.
    Ayehunie S; Sönnerborg A; Desta B; Kefene H; Zewdie D; Britton S; Strannegård O
    AIDS; 1992 Jul; 6(7):651-7. PubMed ID: 1503684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 7-year analysis of anti-Gag (p17 and p24) antibodies in HIV-1-seropositive patients with haemophilia: immunoglobulin G titre and avidity are early predictors of clinical course.
    Chargelegue D; Colvin BT; O'Toole CM
    AIDS; 1993 Nov; 7 Suppl 2():S87-90. PubMed ID: 7909231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appearance of predictors of disease progression in relation to the development of AIDS.
    de Wolf F; Lange JM; Houweling JT; Mulder JW; Beemster J; Schellekens PT; Coutinho RA; van der Noordaa J; Goudsmit J
    AIDS; 1989 Sep; 3(9):563-9. PubMed ID: 2571348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive markers of AIDS: a follow-up of lymphocyte subsets and HIV serology in a cohort of patients with lymphadenopathy.
    Böttiger B; Morfeldt-Månson L; Putkonen P; Nilsson B; Julander I; Biberfeld G
    Scand J Infect Dis; 1989; 21(5):507-14. PubMed ID: 2511625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliable confirmation and quantitation of human immunodeficiency virus type 1 antibody using a recombinant-antigen immunoblot assay.
    Busch MP; el Amad Z; McHugh TM; Chien D; Polito AJ
    Transfusion; 1991 Feb; 31(2):129-37. PubMed ID: 1899951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.